Rancho Santa Fe Bio, Inc. Enters into Worldwide Exclusive License Agreement with Sanofi for Ataciguat SAN DIEGO and PARIS, June 17, 2021 (GLOBE NEWSWIRE) -- Rancho Santa Fe Bio, Inc. (“RSF Bio” or the “Company”), a San Diego, California-based clinical-stage cardiovascular platform company, today...

Retrophin Announces Cooperative Research and Development Agreement with NCATS and the Alagille Syndrome Alliance to Identify Potential Therapeutics for Alagille Syndrome SAN DIEGO, June 18, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that it has entered into a three-way Cooperative Research and Development Agreement (CRADA) with the...

ConverGene Announces a License Agreement With the National Center for Advancing Translational Sciences CAMBRIDGE, Md., Dec. 13, 2016 (GLOBE NEWSWIRE) -- ConverGene has entered into an exclusive license agreement with the National Center for Advancing Translational Sciences (NCATS), part of the...